Abby van Voorhees, MD
Dermatology · Norfolk, VANPI 1326073917
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $55,148 of the $64,084 with a category attached, or 86.1%. 9 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 30.2% of the total. Reporting peaked in 2019 at $21,875 and has fallen 85.7% since, to $3,125 in 2024. Among dermatology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $1732.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$19K
- Boehringer Ingelheim$18K
- Bristol Myers Squibb$9K
- Novartis$7K
- UCB, Inc.$5K
- Amgen$3K
- plus $2K from 3 others
Across 14 payments — averaging $3840.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$21K
- AbbVie$13K
- Bristol Myers Squibb$10K
- Amgen$10K
What the payments were for
- Consulting fees$55,14886%
- Speaking & faculty fees$6,30210%
- Travel & lodging$2,2093%
- Food & beverage$4261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 15 | $19,354 |
| Boehringer Ingelheim | 5 | $18,450 |
| Bristol Myers Squibb | 8 | $9,030 |
| Novartis | 3 | $7,350 |
| UCB, Inc. | 2 | $4,970 |
| Amgen | 1 | $2,625 |
| Boehringer Ingelheim International GmbH | 1 | $2,250 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $30 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$64,084 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bimzelx AutoinjectorBimekizumab-Bkzx | 11 | $160,258 |
| RemicadeInfliximab | 11 | $111,999 |
| Taltz AutoinjectorIxekizumab | 11 | $72,085 |
| Dupixent PenDupilumab | 16 | $59,762 |
| Ketoconazole | 36 | $435 |
| Triamcinolone Acetonide | 27 | $350 |
| Clobetasol Propionate | 14 | $267 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Norfolk
- Jonathan SchreiberNorfolk$330K
- David PariserNorfolk$261K
- Molly SmithNorfolk$11K
- Robert PariserNorfolk$10K
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.